Status:
COMPLETED
Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
European Organisation for Research and Treatment of Cancer - EORTC
Medical University Innsbruck
Conditions:
Covid19, Patient Reported Outcome Measures, Quality of Life
Eligibility:
All Genders
18+ years
Brief Summary
Purpose: to develop an international validated patient-reported outcome measure for COVID-19 patients according to international guidelines. In this phase III of the project, the preliminary question...
Detailed Description
This project aim to develop an international validated patient-reported outcome measure for COVID-19 patients according to international guidelines. The Phase I and II of this development process have...
Eligibility Criteria
Inclusion
- Patients with verified SARS-CoV-2 infection (positive test according to local/national standards)
- Patients with active or previous symptomatic COVID-19 disease
- In-patients in hospitals and nursing homes or out-patients in hospitals or patients discharged from institutions to their home/covid-19 centres or patients staying at home/covid-19 centres during the course of the disease
- Patients aged 18 years and older
- Ability to read and comprehend the process and study documents as judged by the investigator
- Written informed consent
Exclusion
- Patients in intensive care units (can be recruited after they have been dismissed)
- Inability to read and comprehend the process and study documents as judged by the investigator
Key Trial Info
Start Date :
November 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 15 2022
Estimated Enrollment :
371 Patients enrolled
Trial Details
Trial ID
NCT04740372
Start Date
November 20 2020
End Date
September 15 2022
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway, N-0424